Antiviral CD8+ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice
- 27 January 2012
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 18 (1) , 45-54
- https://doi.org/10.1007/s13365-012-0077-2
Abstract
Major histocompatibility complex class I-restricted CD8+ cytotoxic T lymphocytes are involved in the pathogenesis of multiple sclerosis (MS) and both autoimmune, experimental autoimmune encephalomyelitis, and viral, Theiler’s murine encephalomyelitis virus (TMEV) infection, animal models of MS. Following TMEV infection, certain T cell hybridomas, generated from cloned TMEV-induced CD8+ T cells, were able to produce clinical signs of disease (flaccid hind limb paralysis) upon adoptive transfer into naive mice. Dual T cell receptors (TCR) are present on the surface of these cells as both Vβ3 and Vβ6 were detected by polymerase chain reaction (PCR) screening and flow cytometry and multiple Vα mRNAs were detected by PCR screening. This is the first demonstration of antiviral CD8+ T cells having more than one TCR initiating an autoimmune disease in the natural host of the virus. We hypothesize that this is a potential mechanism for virus-induced autoimmune disease initiated by CD8+ T cells.Keywords
This publication has 34 references indexed in Scilit:
- Molecular Mimicry as a Mechanism of Autoimmune DiseaseClinical Reviews in Allergy & Immunology, 2011
- Paired analysis of TCRα and TCRβ chains at the single-cell level in miceJournal of Clinical Investigation, 2011
- Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRsNature Immunology, 2010
- Potential Triggers of MSPublished by Springer Nature ,2009
- Targeting Inflammatory Demyelinating Lesions to Sites of Wallerian DegenerationThe American Journal of Pathology, 2007
- Central Nervous System Pathology Caused by Autoreactive CD8+T-Cell Clones following Virus InfectionJournal of Virology, 2005
- Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?Brain, 2005
- Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infectionEuropean Journal of Immunology, 1997
- T-lymphocyte subsets in the multiple sclerosis lesionResearch in Immunology, 1989
- Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.The Journal of Experimental Medicine, 1986